Final Exam Flashcards
RNA processing
Governs how, when, and whether RNA will be used
in a cell
Primary Transcripts
- All eukaryotic RNAs and some Bacterial RNAs are synthesized as biologically inactive precursors that must be chemically modified during or immediately following transcription
- Cleavage and/or joining of RNA strands and sometimes modification
- Errors in splicing can lead to problems like cystic fibrosis and spinal muscular atrophy
*Once an mRNA transcript has reached the end of its utility in the cell, it is subject to a final type of RNA processing—degradation. Specific enzymes remove the 5′ cap and the 3′ poly(A) tail, and the rest of the RNA is broken down by cleavage of the phosphodiester backbone.
RNA processing is catalyzed by
RNA (splicesome) and Proteins
-different locations in bacteria vs eukaryotes
mRNA RNA processing occurs in?
- In the nucleus
- Post-processing, mRNA is exported to the
cytoplasm
what are the 3 major modifications that occur during mRNA processing?
- 5’ end gets a 7-Methylguanylate cap (protective)
- 3’ end gets a poly A tail 100-250 nt long
- Introns are spliced out
- Regular splicing
- Alternative splicing
What is responsible for the 3 major modifications in mRNA processing
- Enzymes responsible for these three events do not operate independently, they work together
- Processing is also coupled to transport from the nucleus to the cytoplasm
Describe the steps to get from DNA to mRNA
1.Transcription, 5’ capping
2. Endonuclease causes cleavage at the poly-A site
3.Poly A polymerase(PAP) + ATP do polyadenylation
4.RNA splicing occurs
RNA capping has what type of bond
- 5’,5’ triphosphate linkage
What is the name of the capping enzyme?
guanylyltransferase
Describe how capping occurs and why it’s important.
Only RNAs made by RNA pol II are capped because the mechanism is specific to the C terminus of the RNA polymerase
* As the nascent RNA emerges, at about 20-30 nt into the process, capping occurs
—This is one mark of RNA as an mRNA
* crucial for binding of the mRNA to the ribosome during translation
In experiments what happens when the 5’ cap isn’t present?
The 5′ cap requirement for ribosome binding and translation., if the 5’ is missing it is seen that all mRNA is unbound
How long is the Poly A tail and why is it significant to mRNA
- PolyA tail is about 80-250 nt long
- 3’polyadenylated mRNAs survive much longer because they are protected from exonuclease activity through binding of protective enzymes
How is the poly-A tail added?
- PolyA tail is added in multiple steps involving polyadenylation factors, polyadenylate polymerase (PAP), and poly(A) binding protein PABP
- The first thing that happens is that Pol II extends the transcript beyond the site where the polyA tail is to be added
- Cleavage happens at the polyA addition site by an endonuclease enzyme associated with the C terminus of the Pol II enzyme
Polyadenyoaton factors are associated with?
Pol 2 during transcription
mRNA capping polyadenylation and splicing are coordinated by
- All about the association with Pol II
- The C terminus of the Pol II proteins associates
with factors involved in these processes - RNA processing can therefore basically occur simultaneously with transcription
- This leads to rapid processing and production of mature mRNAs
What does the Splicing and editing do for the proteome
-both splicing and editing expand the coding capacity of the genome by creating mRNA that is directly encoded by the DNA
-Proteome shows that in any case the number of different proteins greatly exceeds the number of identified genes.
What is splicing and what are some of the aspect due to splicing?
- Splicing (does not occur in bacteria)
-Ordered breaking and joining of specific phosphodiester bonds to - Splicing also prepares mRNAs to be recognized by proteins that export them from the nucleus and promote their translation by the ribosome.
achieve the precise excision of introns - Requires accurate base pairing between pre-mRNA and splicing machinery
- Spliceosome is responsible for most splicing
- Small number of introns found in mitochondria, chloroplast, and bacteriophage are self-splicing
Describe introns
- In vertebrates, the vast majority of genes contain introns
- Histone genes are an absolute exception
- Most genes in simpler eukaryotes like yeast, lack
introns but some have them - Very rare but do occur in bacteria and archaea
- Very rare but do occur in some bacteriophage
- Introns seem to be important for the amount of mature mRNA that is produced
- Regulatory small RNAs for example come from introns often
- Are transcribed as part of the transcription process
- Size 50-20000 nucleotides while exons are 100- 1000 nt
what did the DNA-RNA hybrid reveal
the presence of introns
what is the typical intron length in mammals
pre-mRNA includes eight introns with an aggregate length 5 to 10 times that of the flanking exons.
What is Alternative splicing?
Process in which exons in the primary transcript from a single gene are spliced together in various combinations to produce different mRNAs and thus different polypeptides
Describe some of the aspects seen due to alternative splicing
When we compare an organism’s genome to its proteome, in many cases, the number of different proteins greatly exceeds the number of different genes
* More than 90% of human genes undergo alternative splicing
* Certain exons are selected for inclusions and others are not, but the order of the exons does not change relative to the primary transcript
* Many mammalian genes have 2 or more alternatively spliced mRNAs (splice variants)
How does alternative splicing work?
- We don’t fully understand it
- Splice sites—nucleotide sequences within the intron and at the borders between introns and exons seem to be important
-Sometimes these sequences can be masked on purpose
Why is alternative splicing important?
- Alternative splicing can be important for human disease
-CD44 which is a cell surface receptor
— Inclusion of a specific exon in the spliced mRNAs is associated with the progression of certain tumors from localized to invasive growth
— Thus, understanding what determines exon choice during alternative splicing might lead to new therapeutic strategies to treat or prevent some cancers.